TTK Healthcare Limited (NSE:TTKHLTCARE)

Market Cap	12.62B -27.3%
Revenue (ttm)	8.30B +4.7%
Net Income	600.67M -28.3%
EPS	42.51 -28.3%
Shares Out	n/a
PE Ratio	21.02
Forward PE	n/a
Dividend	10.00 (1.12%)
Ex-Dividend Date	Jul 18, 2025

Volume	805
Average Volume	1,657
Open	896.60
Previous Close	888.55
Day's Range	882.80 - 900.10
52-Week Range	735.00 - 1,398.90
Beta	0.31
RSI	47.67
Earnings Date	May 30, 2026

About TTK Healthcare

TTK Healthcare Limited engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, and Others segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, antiparasiticides, antispasmodics, cervical dilators, cocktail enzymes, etc. to veterinarians, dairy, poultry and aqua farmers, and pet parents. The Consumer Products segment...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1928
• Employees: 1,339
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: TTKHLTCARE

Financial Performance

In fiscal year 2025, TTK Healthcare's revenue was 8.01 billion, an increase of 6.47% compared to the previous year's 7.53 billion. Earnings were 816.57 million, an increase of 29.94%.